{
  "docId": "019de073-9ed2-75f5-b4c4-69324b7a8310",
  "docSlug": "d4b095284b050177fedb9bcc804883cf",
  "documentTitle": "Albireo Pharma | Results Presentation Deck | 18 slides",
  "authorId": "albireo-pharma",
  "authorName": "Albireo Pharma",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7761332,
  "pageNumber": 4,
  "pageCount": 18,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "cover",
  "function": "front_matter",
  "density": "sparse",
  "nDataPoints": 0,
  "notes": "The slide uses a stylized logo for the ASSERT study.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-9ed2-75f5-b4c4-69324b7a8310/4",
  "deckHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310",
  "deckJsonHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310.json",
  "deckAnchorHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.3,
        "x": 0.35,
        "y": 0.94
      },
      "kind": "disclaimer",
      "text": "For Media & Investors Only\n©2022 Albireo Pharma, Inc. All rights reserved",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7153f586-34ee-4651-9453-575953810b8c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.54,
        "x": 0.23,
        "y": 0.35
      },
      "kind": "title",
      "text": "ASSERT",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "be8c1fca-6ae8-404e-baa9-6db54bb7c77c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.5,
        "x": 0.25,
        "y": 0.65
      },
      "kind": "title",
      "text": "POSITIVE TOPLINE DATA RESULTS\nBylvay® (odevixibat) in Alagille Syndrome Patients",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a3816feb-95aa-4713-9e37-c33dd5486199",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Slide recipe: Cover",
      "slug": "cover-slide",
      "agent": "designer",
      "layer": "slide",
      "matchId": "cce681ed-4aa3-4ef6-bf69-1a2e5731c2b2",
      "evidence": "ASSERT: POSITIVE TOPLINE DATA RESULTS",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}